Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metyrapone vs Osilodrostat in MACS
NCT07268222Phase 4Recruiting
- Sponsor
- Laiko General Hospital
- Start
- Dec 2025
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of metyrapone, osilodrostat in Autonomous Cortisol Secretion (ACS), sponsored by Laiko General Hospital. Started Dec 2025; status: recruiting.
02
Drugs
metyraponeosilodrostat
03
Conditions
Autonomous Cortisol Secretion (ACS)
Beyond the preview
Go deeper on NCT07268222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07268222.